Individualization of dose and fractionation of radiotherapy for head and neck cancers

被引：0
作者：
Blanchard, P. [1 ,2 ,3 ]
Biau, J. [4 ,5 ,6 ]
Castelli, J. [7 ,8 ,9 ]
Tao, Y. [1 ]
Graff, P. [10 ]
Nguyen, F. [1 ]
机构：
[1] Gustave Roussy, Dept Radiotherapie Oncol, Canc Campus,114 Rue Edouard Vaillant, F-94800 Villejuif, France
[2] CESP, INSERM, U1018, F-94800 Villejuif, France
[3] Univ Paris Saclay, F-94800 Villejuif, France
[4] Ctr Jean Perrin, Dept Radiotherapie Oncol, F-63000 Clermont Ferrand, France
[5] Univ Clermont Auvergne, F-63000 Clermont Ferrand, France
[6] INSERM, Imagerie Mol & Strat Theranost U1240, F-63000 Clermont Ferrand, France
[7] Ctr Eugene Marquis, Dept Radiotherapie, F-35000 Rennes, France
[8] INSERM, LTSI U1099, F-35000 Rennes, France
[9] Univ Rennes 1, F-35000 Rennes, France
[10] IUCT Oncopole, Dept Radiotherapie, F-31000 Toulouse, France
来源：
CANCER RADIOTHERAPIE | 2019年 / 23卷 / 6-7期
关键词：
Head and neck cancer; Nasopharyngeal cancer; Chemotherapy; Epstein-Barr virus; Meta-analysis; Radiotherapy; Fractionation; SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; TARGET VOLUMES CTV; HUMAN-PAPILLOMAVIRUS; RANDOMIZED-TRIAL; CONVENTIONAL RADIOTHERAPY; OROPHARYNGEAL CANCER; RADIATION-THERAPY; QUALITY-ASSURANCE; DE-ESCALATION;
D O I：
10.1016/j.canrad.2019.07.131
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Head and neck cancers comprise a variety of tumours depending on the sub-site, for which target volumes and the prescribed doses need to be individualized according to each patient's history and presentation. This article aims at describing the main factors involved in decision-making regarding dose and volume, as well as ongoing research. Contouring and treatment guidelines, use of altered fractionation, major prognostic factors, the role of Human papillomavirus and of functional imaging will be presented and discussed. (C) 2019 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：784 / 788
页数：5
相关论文
共 50 条
  • [41] Impacts of Radiotherapy Fractionation on Outcome in Squamous Cell Head and Neck Cancer (SQC HNC)
    Jeremic, Branislav
    Ozyigit, Gokhan
    Jeremic, Marta
    Dubinsky, Pavol
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2020, 35 (03): : 356 - 362
  • [42] Genetics and management of locally advanced carcinomas of the head and neck: role of altered fractionation radiotherapy
    Perri, Francesco
    Ionna, Franco
    Muto, Paolo
    Di Marzo, Massimiliano
    Caponigro, Francesco
    Longo, Francesco
    Della, Giuseppina
    Scarpati, Vittoria
    Di Lorenzo, Giuseppe
    Giuliano, Mario
    Solla, Raffaele
    FUTURE SCIENCE OA, 2019, 5 (01):
  • [43] Opportunities and challenges in combining immunotherapy and radiotherapy in head and neck cancers
    Wong, Kenneth C. W.
    Johnson, David
    Hui, Edwin P.
    Lam, Rachel C. T.
    Ma, Brigette B. Y.
    Chan, Anthony T. C.
    CANCER TREATMENT REVIEWS, 2022, 105
  • [44] Head and Neck Cancers, Version 1.2022 Featured Updates to the NCCN Guidelines
    Caudell, Jimmy J.
    Gillison, Maura L.
    Maghami, Ellie
    Spencer, Sharon
    Pfister, David G.
    Adkins, Douglas
    Birkeland, Andrew C.
    Brizel, David M.
    Busse, Paul M.
    Cmelak, Anthony J.
    Colevas, A. Dimitrios
    Eisele, David W.
    Galloway, Thomas
    Geiger, Jessica L.
    Haddad, Robert, I
    Hicks, Wesley L.
    Hitchcock, Ying J.
    Jimeno, Antonio
    Leizman, Debra
    Mell, Loren K.
    Mittal, Bharat B.
    Pinto, Harlan A.
    Rocco, James W.
    Rodriguez, Cristina P.
    Savvides, Panayiotis S.
    Schwartz, David
    Shah, Jatin P.
    Sher, David
    St John, Maie
    Weber, Randal S.
    Weinstein, Gregory
    Worden, Frank
    Bruce, Justine Yang
    Yom, Sue S.
    Zhen, Weining
    Burns, Jennifer L.
    Darlow, Susan D.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (03): : 224 - 234
  • [45] Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck-results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer"
    Schuettrumpf, Lars
    Marschner, Sebastian
    Scheu, Katrin
    Hess, Julia
    Rietzler, Sibylle
    Walch, Axel
    Baumeister, Philipp
    Kirchner, Thomas
    Ganswindt, Ute
    Zitzelsberger, Horst
    Belka, Claus
    Maihoefer, Cornelius
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [46] Imaging of Neck Nodes in Head and Neck Cancers- a Comprehensive Update
    Bhattacharya, K.
    Mahajan, A.
    Vaish, R.
    Rane, S.
    Shukla, S.
    D'Cruz, A. K.
    CLINICAL ONCOLOGY, 2023, 35 (07) : 429 - 445
  • [47] Combining Radiotherapy and Immunotherapy in Head and Neck Cancer
    Runnels, Juliana
    Bloom, Julie R.
    Hsieh, Kristin
    Dickstein, Daniel R.
    Shi, Yuhao
    Jones, Brianna M.
    Lehrer, Eric J.
    Bakst, Richard L.
    BIOMEDICINES, 2023, 11 (08)
  • [48] Altered-fractionated radiotherapy in locally advanced head and neck cancer
    Bernier, Jacques
    Horiot, Jean-Claude
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (03) : 223 - 228
  • [49] Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma
    Krstevska, V.
    JOURNAL OF BUON, 2009, 14 (03): : 361 - 373
  • [50] Nutritional Support in Head and Neck Radiotherapy Patients Considering HPV Status
    Brewczynski, Adam
    Jablonska, Beata
    Mrowiec, Slawomir
    Skladowski, Krzysztof
    Rutkowski, Tomasz
    NUTRIENTS, 2021, 13 (01) : 1 - 25
12345